Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Latest News for: ma'at

Edit

Availability of MaaT Pharma’s 2024 Universal Registration Document (URD) (Maat Pharma SA)

Public Technologies 14 Apr 2025
Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients ... Distributed via , unedited and unaltered, on April 14, 2025 at 16.21 UTC.
Edit

MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT (Maat Pharma SA)

Public Technologies 08 Apr 2025
Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients ... Distributed via , unedited and unaltered, on April 08, 2025 at 05.36 UTC.
Edit

April 8, 2025: MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT (Maat Pharma SA)

Public Technologies 08 Apr 2025
Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients ... Distributed via , unedited and unaltered, on April 08, 2025 at 05.36 UTC.
Edit

Inside Information / Other news releases (Maat Pharma SA)

Public Technologies 08 Apr 2025
pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients ... Distributed via , unedited and unaltered, on April 08, 2025 at 07.11 UTC.
Edit

MaaT Pharma Announces Initiation of Coverage of its Stock by H.C. Wainwright & Co (Maat Pharma SA)

Public Technologies 07 Apr 2025
Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients ... Distributed via , unedited and unaltered, on April 07, 2025 at 05.39 UTC.
Edit

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the ...

Business Wire 05 Apr 2025
MaaT Pharma (EURONEXT. MAAT – the “Company”), a clinical-stage biotechnology company and a leader in ...
Edit

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital (Maat Pharma SA)

Public Technologies 04 Apr 2025
Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients ... Distributed via , unedited and unaltered, on April 04, 2025 at 16.10 UTC.
  • 1
×